Probing nanoliposomes using single particle analytical techniques: effect of excipients, solvents, phase transition and zeta potential
M. Danaei,
M. Kalantari,
M. Raji,
H. Samareh Fekri,
R. Saber,
G.P. Asnani,
S.M. Mortazavi,
M.R. Mozafari,
B. Rasti,
A. Taheriazam
Affiliations
M. Danaei
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
M. Kalantari
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
M. Raji
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
H. Samareh Fekri
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
R. Saber
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
G.P. Asnani
Sinhgad Technical Education Society's, Smt. Kashibai Navale College of Pharmacy, Kondhwa, Pune 411 048, (Savitribai Phule Pune University), Maharashtra, India
S.M. Mortazavi
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
M.R. Mozafari
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia
B. Rasti
Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, 3168 Victoria, Australia; Faculty of Food Science and Nutrition, Universiti Malaysia Sabah, Jalan UMS, 88400 Kota Kinabalu, Sabah, Malaysia; Corresponding author.
A. Taheriazam
Department of Orthopaedics, Tehran Medical Sciences Branch IAU, Azad University, 19168 93813 Tehran, Iran; Corresponding author.
There has been a steady increase in the interest towards employing nanoliposomes as colloidal drug delivery systems, particularly in the last few years. Their biocompatibility nature along with the possibility of encapsulation of lipid-soluble, water-soluble and amphipathic molecules and compounds are among the advantages of employing these lipidic nanocarriers. A challenge in the successful formulation of nanoliposomal systems is to control the critical physicochemical properties, which impact their in vivo performance, and validating analytical techniques that can adequately characterize these nanostructures. Of particular interest are the chemical composition of nanoliposomes, their phase transition temperature, state of the encapsulated material, encapsulation efficiency, particle size distribution, morphology, internal structure, lamellarity, surface charge, and drug release pattern. These attributes are highly important in revealing the supramolecular arrangement of nanoliposomes and incorporated drugs and ensuring the stability of the formulation as well as consistent drug delivery to target tissues. In this article, we present characterization of nanoliposomal formulations as an example to illustrate identification of key in vitro characteristics of a typical nanotherapeutic agent. Corresponding analytical techniques are discussed within the context of nanoliposome assessment, single particle analysis and ensuring uniform manufacture of therapeutic formulations with batch-to-batch consistency.